Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Schellong

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
The Lancet. Haematology|July 2, 2022
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trialFrank Cools, Saverio Virdone, Jitendra Sawhney, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 3, 2021
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTECarlos Jerjes-Sánchez, David Rodriguez, Alfredo E Farjat, et al.
Thrombosis Research|December 24, 2022
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTEAlexander G G Turpie, Alfredo E Farjat, Sylvia Haas, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|December 1, 2022
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal DiseaseSylvia Haas, Alfredo E Farjat, Karen Pieper, et al.
Journal of the American College of Cardiology|March 25, 2017
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary EmbolismStavros V Konstantinides, Eric Vicaut, Thierry Danays, et al.
Thrombosis and Haemostasis|September 24, 2021
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trialOlivier Sanchez, Anaïs Charles-Nelson, Walter Ageno, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 20, 2018
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trialStefano Barco, Mariaconcetta Russo, Eric Vicaut, et al.
Thrombosis and Haemostasis|December 7, 2017
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 StudyFrederikus A Klok, Walter Ageno, Stefano Barco, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 20, 2022
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2Anna C Mavromanoli, Stefano Barco, Walter Ageno, et al.
Research and Practice in Thrombosis and Haemostasis|July 19, 2021
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarinRoisin Bavalia, Ingrid M Bistervels, Wim G Boersma, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
The Lancet. Haematology|July 2, 2022
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trialFrank Cools, Saverio Virdone, Jitendra Sawhney, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 3, 2021
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTECarlos Jerjes-Sánchez, David Rodriguez, Alfredo E Farjat, et al.
Thrombosis Research|December 24, 2022
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTEAlexander G G Turpie, Alfredo E Farjat, Sylvia Haas, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|December 1, 2022
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal DiseaseSylvia Haas, Alfredo E Farjat, Karen Pieper, et al.
Journal of the American College of Cardiology|March 25, 2017
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary EmbolismStavros V Konstantinides, Eric Vicaut, Thierry Danays, et al.
Thrombosis and Haemostasis|September 24, 2021
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trialOlivier Sanchez, Anaïs Charles-Nelson, Walter Ageno, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 20, 2018
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trialStefano Barco, Mariaconcetta Russo, Eric Vicaut, et al.
Thrombosis and Haemostasis|December 7, 2017
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 StudyFrederikus A Klok, Walter Ageno, Stefano Barco, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 20, 2022
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2Anna C Mavromanoli, Stefano Barco, Walter Ageno, et al.
Research and Practice in Thrombosis and Haemostasis|July 19, 2021
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarinRoisin Bavalia, Ingrid M Bistervels, Wim G Boersma, et al.
Pageof 12